Peguis Pharmacies Receive Shipment of COVID-19 Vaccines
We are pleased to announce that all our pharmacy locations have received doses of COVID-19 vaccines. However; due to the short supply, individuals must meet the criteria to be eligible must phone their local Peguis Pharmacy to make an appointment.
The (standard) COVID-19 Immunization Consent Form MUST be completed prior to completing this Enhanced Consent Form. Individuals who are pregnant, planning to become pregnant or breastfeeding; immunosuppressed due to disease or treatment and/or have an autoimmune condition are to complete two consent forms.
Eligibility Criteria
As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.
Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.
However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.
People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.
Priority List 1:
- Individuals with the following chronic health conditions:
- end stage renal disease undergoing hemodialysis OR peritoneal dialysis
- cirrhosis due to any cause OR portal hypertension
- heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
- severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
- history of cerebral vascular accident with residual deficits
- malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
- malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
- severe obesity (BMI ≥ 40)
- receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
- solid organ or hematopoietic stem cell transplant (candidate or recipient)
- trisomy 21 (Down syndrome)
- asplenia or hyposplenism (including sickle cell disease)
- Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.
- Pregnant individuals (18 to ≤ 64 years of age) with one of: aged ≥ 35 years, BMI ≥ 30, pre-existing diabetes, pre-existing hypertension, cardiac or pulmonary disease.
Priority List 2:
- Individuals with the following chronic health conditions:
- Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
- chronic liver disease
- chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
- chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
- chronic renal disease
- HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
- severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
- type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
- active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
- receiving immunosuppressing therapy
- Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
- Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents
LOCATIONS
Chief Peguis Pharmacy
Peguis Mall
204 645 5935
Peguis Pharmacy – Selkirk
103-620 Manitoba Ave
204 482 8353
Peguis Pharmacy – Winnipeg
102-1065 Portage Ave
204 774 0043